Aicardi-Goutières syndrome: A description of 21 new cases and a comparison with the literature

Giovanni Lanzi, Elisa Fazzi, Stefano D'Arrigo

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The International Aicardi-Goutières Syndrome Association (IAGSA) was founded in 2000, its aim being to collect and analyse all available information on this rare syndrome (whose true incidence is not known) in order to increase knowledge of the pathology and the number of reported cases. We analysed the clinical, neuroradiological and biological characteristics of 21 new Aicardi-Goutières syndrome subjects (seven observed directly and 14 on whom we gathered detailed clinical information) and compared our findings with data in the literature. The main clinical symptoms (pyramidal and extrapyramidal symptoms, psychomotor delay, microcephaly) and neuroradiological features (basal ganglia calcification, atrophy, white matter alterations) observed show a greater homogeneity in our subjects than in the literature cases, which indicates an improvement in the diagnostic accuracy of Aicardi-Goutières syndrome. Other symptoms, such as feeding difficulties and irritability are less frequent, but characteristic and present early (even at onset of the disease). In the literature, doubts are expressed as to whether lymphocytosis and/or raised interferon-alpha in cerebrospinal fluid are crucial for a diagnosis of Aicardi-Goutières syndrome. Our data suggest that they are, and in particular that an important role is played by raised interferon-alpha. The clinical course seems to show different stages: early onset, rapid progression, severe deterioration, stabilization. Our follow-up seems to indicate a trend not necessarily towards a worsening, but instead towards a stabilization or even a slight improvement of the clinical picture.

Original languageEnglish
JournalEuropean Journal of Paediatric Neurology
Volume6
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2002

Fingerprint

Aicardi Syndrome
Interferon-alpha
Lymphocytosis
Microcephaly
Basal Ganglia
Atrophy
Cerebrospinal Fluid
Pathology
Incidence

Keywords

  • Aicardi-Goutières syndrome
  • Basal ganglia calcifications
  • Chronic lymphocytosis
  • Clinical course
  • Interferon-alpha
  • Leukodystrophy

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Neurology

Cite this

Aicardi-Goutières syndrome : A description of 21 new cases and a comparison with the literature. / Lanzi, Giovanni; Fazzi, Elisa; D'Arrigo, Stefano.

In: European Journal of Paediatric Neurology, Vol. 6, No. SUPPL. 1, 2002.

Research output: Contribution to journalArticle

@article{3b07c1c20f624a42af88749515be1953,
title = "Aicardi-Gouti{\`e}res syndrome: A description of 21 new cases and a comparison with the literature",
abstract = "The International Aicardi-Gouti{\`e}res Syndrome Association (IAGSA) was founded in 2000, its aim being to collect and analyse all available information on this rare syndrome (whose true incidence is not known) in order to increase knowledge of the pathology and the number of reported cases. We analysed the clinical, neuroradiological and biological characteristics of 21 new Aicardi-Gouti{\`e}res syndrome subjects (seven observed directly and 14 on whom we gathered detailed clinical information) and compared our findings with data in the literature. The main clinical symptoms (pyramidal and extrapyramidal symptoms, psychomotor delay, microcephaly) and neuroradiological features (basal ganglia calcification, atrophy, white matter alterations) observed show a greater homogeneity in our subjects than in the literature cases, which indicates an improvement in the diagnostic accuracy of Aicardi-Gouti{\`e}res syndrome. Other symptoms, such as feeding difficulties and irritability are less frequent, but characteristic and present early (even at onset of the disease). In the literature, doubts are expressed as to whether lymphocytosis and/or raised interferon-alpha in cerebrospinal fluid are crucial for a diagnosis of Aicardi-Gouti{\`e}res syndrome. Our data suggest that they are, and in particular that an important role is played by raised interferon-alpha. The clinical course seems to show different stages: early onset, rapid progression, severe deterioration, stabilization. Our follow-up seems to indicate a trend not necessarily towards a worsening, but instead towards a stabilization or even a slight improvement of the clinical picture.",
keywords = "Aicardi-Gouti{\`e}res syndrome, Basal ganglia calcifications, Chronic lymphocytosis, Clinical course, Interferon-alpha, Leukodystrophy",
author = "Giovanni Lanzi and Elisa Fazzi and Stefano D'Arrigo",
year = "2002",
doi = "10.1053/ejpn.2002.0568",
language = "English",
volume = "6",
journal = "European Journal of Paediatric Neurology",
issn = "1090-3798",
publisher = "W.B. Saunders Ltd",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Aicardi-Goutières syndrome

T2 - A description of 21 new cases and a comparison with the literature

AU - Lanzi, Giovanni

AU - Fazzi, Elisa

AU - D'Arrigo, Stefano

PY - 2002

Y1 - 2002

N2 - The International Aicardi-Goutières Syndrome Association (IAGSA) was founded in 2000, its aim being to collect and analyse all available information on this rare syndrome (whose true incidence is not known) in order to increase knowledge of the pathology and the number of reported cases. We analysed the clinical, neuroradiological and biological characteristics of 21 new Aicardi-Goutières syndrome subjects (seven observed directly and 14 on whom we gathered detailed clinical information) and compared our findings with data in the literature. The main clinical symptoms (pyramidal and extrapyramidal symptoms, psychomotor delay, microcephaly) and neuroradiological features (basal ganglia calcification, atrophy, white matter alterations) observed show a greater homogeneity in our subjects than in the literature cases, which indicates an improvement in the diagnostic accuracy of Aicardi-Goutières syndrome. Other symptoms, such as feeding difficulties and irritability are less frequent, but characteristic and present early (even at onset of the disease). In the literature, doubts are expressed as to whether lymphocytosis and/or raised interferon-alpha in cerebrospinal fluid are crucial for a diagnosis of Aicardi-Goutières syndrome. Our data suggest that they are, and in particular that an important role is played by raised interferon-alpha. The clinical course seems to show different stages: early onset, rapid progression, severe deterioration, stabilization. Our follow-up seems to indicate a trend not necessarily towards a worsening, but instead towards a stabilization or even a slight improvement of the clinical picture.

AB - The International Aicardi-Goutières Syndrome Association (IAGSA) was founded in 2000, its aim being to collect and analyse all available information on this rare syndrome (whose true incidence is not known) in order to increase knowledge of the pathology and the number of reported cases. We analysed the clinical, neuroradiological and biological characteristics of 21 new Aicardi-Goutières syndrome subjects (seven observed directly and 14 on whom we gathered detailed clinical information) and compared our findings with data in the literature. The main clinical symptoms (pyramidal and extrapyramidal symptoms, psychomotor delay, microcephaly) and neuroradiological features (basal ganglia calcification, atrophy, white matter alterations) observed show a greater homogeneity in our subjects than in the literature cases, which indicates an improvement in the diagnostic accuracy of Aicardi-Goutières syndrome. Other symptoms, such as feeding difficulties and irritability are less frequent, but characteristic and present early (even at onset of the disease). In the literature, doubts are expressed as to whether lymphocytosis and/or raised interferon-alpha in cerebrospinal fluid are crucial for a diagnosis of Aicardi-Goutières syndrome. Our data suggest that they are, and in particular that an important role is played by raised interferon-alpha. The clinical course seems to show different stages: early onset, rapid progression, severe deterioration, stabilization. Our follow-up seems to indicate a trend not necessarily towards a worsening, but instead towards a stabilization or even a slight improvement of the clinical picture.

KW - Aicardi-Goutières syndrome

KW - Basal ganglia calcifications

KW - Chronic lymphocytosis

KW - Clinical course

KW - Interferon-alpha

KW - Leukodystrophy

UR - http://www.scopus.com/inward/record.url?scp=10944240851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10944240851&partnerID=8YFLogxK

U2 - 10.1053/ejpn.2002.0568

DO - 10.1053/ejpn.2002.0568

M3 - Article

C2 - 12365365

AN - SCOPUS:10944240851

VL - 6

JO - European Journal of Paediatric Neurology

JF - European Journal of Paediatric Neurology

SN - 1090-3798

IS - SUPPL. 1

ER -